Tag | Content |
---|
EnhancerAtlas ID | HS104-38552 |
Organism | Homo sapiens |
Tissue/cell | HUVEC |
Coordinate | chr22:29765900-29767950 |
TF binding sites/motifs | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
HES2 | MA0616.2 | chr22:29767585-29767595 | GGCACGTGCC | + | 6.02 | HES2 | MA0616.2 | chr22:29767585-29767595 | GGCACGTGCC | - | 6.02 | IRF1 | MA0050.2 | chr22:29766447-29766468 | AAAAAAAAAAAGAAAGAAAGA | - | 6.25 |
|
| Number of super-enhancer constituents: 1 | ID | Coordinate | Tissue/cell |
SE_11767 | chr22:29766390-29768678 | CD20 |
|
| Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | Number of disease enhancers: 3 | Chromosome | Start | End |
chr22 | 29766508 | 29766778 | chr22 | 29766519 | 29766958 | chr22 | 29766258 | 29766308 |
|
| Number: 2 | ID | Chromosome | Start | End |
GH22I029368 | chr22 | 29764881 | 29766170 | GH22I029370 | chr22 | 29766514 | 29767027 |
|
Enhancer Sequence | TGGGGACCTC TGAAAATGGG CAGGTAAATC AGATAATGGG ATTTCTGTCT TACAATAAAG 60 ATCTGCATGG TTCCAGAAGT CACAGACTTG AGAGTGTAAC TGCCAAAAGT ATCCAAAATA 120 ATAGGATAAT ATCATTTCTC AAGGTTGAGT GTAAGAGGGA TAACTGAAGA CAAAAGGGGC 180 TAAAACTCAC AGGCCACAAA GAAACACAGA AAGTAACACA GAAACCACTC CAACATTAAA 240 TCTAAAAAGA AACAAAAGTG GCCGGGCGTG GTGGCTCATG CCTGTAATCC TAGCACTTTG 300 GGAGGCTGAG GTGGGCAGAT TGCCTGAGCT CAGGAGTTTG AGACCAGCCT GGGCAACATA 360 GTGAAACCCC GTCGCTACTA AAATACAAAA AATTAGCTGG GCGTGGTGGC ATGTGCCTGT 420 AGTCCCAGCT ACTCGGGAGG CTGAGGCAAG AGAATTGCTT GAACTCAGGA GGTGGAGACT 480 GCAGTGAGCT GAGATCGTGC CACTGCACTC CAGCCCGAGC GACAGAGTGA GACTCAGTCT 540 CAAAAAAAAA AAAAAAAAGA AAGAAAGAAA GAAAGAAAAG TGAATAAAAC AAACAAAATA 600 CCTTAGATAA CTAATGTGAG AGCTGCTCGG AATTTCTTGC CTCTCCAGAA GAAAAAGCCG 660 TCAGAGCCTG TCCCCTCCCC TGCAGGCCCA ATACAACATC AGAGGGCCCT AAATTCCCAG 720 GACGCAACCT GCTGGTGACA GATGGGTGCT GTATGCAACT GACCAAGAGG AGAAACGGGT 780 GAGAAAGCCT TTCTTTCTGG GGATTTAAAA AAAAAGTGAC AGAGCTGCAG GGTAGCTGGT 840 CAAAGCACAG CTGCAGGGTA GCTGGTCAAA GCACAGCTGC AGATACCCCA ACAGCGCTGA 900 GCTTTCCGTG ACAGTCTTCC TTTTACAGGT GCTAAGCAAC TACTCACAAA CTTAACTGCC 960 ACTCAGTGCA CTGGTGCTGG CTGCAGCTTT TTTCCGCAGT ATCTGTTTCA CATATCCCTC 1020 TGCAGAGGGC CCAATGGGAC TGATGATGCA GAAATGTATC CCTCTGAAGT TGTTTCATAT 1080 GCAGGAAATT AAAGTAGAGA AGGGAGGAGA TGCGGAGAAA AGTGAAACGC TTTAGAAAGC 1140 CACCCCAAAA CACAGATAAC AAAACAAAAC AAAACACCTC ACTTCACCAT GAATGATTCC 1200 CTACCTACAG CTTAGTGATG TACTGAGGGC AGCTATCTCC TCGTGTCCTT TCTCCATTGT 1260 GAGCACCTAA TGCTGGTACC TGGTCTTGCA GTTGCCTCTT GGATGGATAT CAGTGCAAGA 1320 GATTTCTCAT TCTCTCCGCA GGAATGGAAA AAACCCTACA GTTCAGTCCT AACGGGGCTC 1380 AGACTCATAG ATGCCATGAG AAAGACTGGT GTTTTTCCTG GCACCTGCTT GGCTGTTATC 1440 ATGCACTGTA TCCCTACCCC ATAGAGGCCA AAGGGGCTGA GACCTTGTTC TCTGATGAAT 1500 CTGATCGGGT ACACGAATCA TATTTGAAAG CAGGCAGCGG CTGGGCGCGG TGGCTTATGC 1560 CTGTAATCCC AGCACTTTGG GAGGCTGAGG TGGGCAGATC ACGAGGTCAG GAGATCGAGA 1620 CCATCCTGGC TAACATGGTG AAACCCCATC TCTATGAAAA ATAAAAAAAA TTAGCCGGGT 1680 GTGGTGGCAC GTGCCTGTAG TTCCAGTTAC TCAGGAGGCT GAGGCAGGAG AAGCATGAAC 1740 CCAGAGGCGG AGCTTGCAGT GAGCAGAGAT CGCGCCACTG CACTCTAGCT TGGGCGACAG 1800 AGTGAGACTC CGTCTCAAAA AAAAAAAGCC AGCAAATTTA GGCAAGAAAA AGCTTAGGGT 1860 TTGGATTCCA TCTTTGGAAG TGTCAGGGCA AATTTTTTAA AGTGGTTAAT TACGGGGAAT 1920 TTTTGATTCA GAAACTGCTC TGGCCAGTAT AATGAGTCAC TTTGCTAAGG AGACAGCATT 1980 CTGGGCTGGG ATCCCCCCCT CAATTTCAGC ATTTACAGGC CAAGAAATGC CTCAAGGGGA 2040 TGGCATGGTC 2050
|